Cytokines produced by Her-2 responders in young breast cancer patients
| Young (n = 35) | ||||
|---|---|---|---|---|
| CD4 | Response | No. of patients | % Dead | P value |
| TNF | Yes | 27 | 7 | 0.5 |
| No | 8 | 0 | ||
| IFN-γ | Yes | 28 | 7 | 0.6 |
| No | 7 | 0 | ||
| IL-5 | Yes | 8 | 25 | 0.04 |
| No | 27 | 0 | ||
| IL-10 | Yes | 4 | 0 | 0.7 |
| No | 31 | 6 | ||
| IL-2 | Yes | 22 | 9 | 0.4 |
| No | 13 | 0 | ||
| IL-17 | Yes | 6 | 17 | 0.6 |
| No | 29 | 3 | ||
| IL-5 and or IL-17 | Yes | 12 | 17 | 0.1 |
| No | 23 | 0 | ||
| CD8 | ||||
| TNF | Yes | 16 | 13 | 0.3 |
| No | 19 | 0 | ||
| IFN-γ | Yes | 18 | 11 | 0.3 |
| No | 17 | 0 | ||
| IL-10 | Yes | 2 | 0 | 0.3 |
| No | 33 | 6 | ||
| IL-2 | Yes | 2 | 0 | 0.8 |
| No | 33 | 6 | ||
Results of survival analysis according to Kaplan Meier method and p values from Mantel-Cox (log-rank) test